KalVista Pharmaceuticals, Inc. ($KALV)
Filing Information
| Accession Number | 0001827505-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 20, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
14,362
Total Value
$37,642.75
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Common Stock | โ | Apr 16, 2026 | Exercise/Conversion | 6,250 | โ | โ | 53,253 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Apr 17, 2026 | Sale | 1,862 | $20.22 | $37,642.75 | 51,391 | Direct | โ | View Details | |
Chief Commercial Officer | Restricted Stock Unit | Derivative | Apr 16, 2026 | Exercise/Conversion | 6,250 | $0.00 | $0.00 | 93,750 | Direct | โ | View Details |